Literature DB >> 23381670

Phosphoprotein Phosphatase PP2A Regulation of Insulin Receptor Substrate 1 and Insulin Metabolic Signaling.

Chirag Mandavia1, James R Sowers.   

Abstract

Insulin (INS) metabolic signaling is important for normal cardiovascular and renal function as well as for exerting the classic actions of INS, such as glucose uptake in skeletal muscle tissue. There is emerging evidence that tyrosine phosphatases as well as protein kinases have important modulating roles in INS metabolic signaling in both cardiovascular and classically INS- sensitive tissues. For example, increases in phosphatase activity may partially explain how angiotensin II and aldosterone attenuate activation of the INS receptor substrate protein 1 (IRS-1)-phosphatidylinositol 3 kinase-protein kinase B pathway, thereby promoting INS resistance. On the other hand, phosphatase activation may also exert beneficial and cardiovascular protective effects in conditions such as overnutrition by blocking serine phosphorylation of IRS-1, thereby improving downstream INS metabolic signaling. Both the beneficial and the detrimental effects exerted by the activation of phosphatases will be covered in this report.

Entities:  

Year:  2012        PMID: 23381670      PMCID: PMC3551395          DOI: 10.1159/000343889

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  38 in total

1.  Role of mTOR in the degradation of IRS-1: regulation of PP2A activity.

Authors:  David Hartley; Geoffrey M Cooper
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

2.  Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes.

Authors:  K Egawa; N Nakashima; P M Sharma; H Maegawa; Y Nagai; A Kashiwagi; R Kikkawa; J M Olefsky
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

3.  PP2A regulatory subunit PP2A-B' counteracts S6K phosphorylation.

Authors:  Katrin Hahn; Merce Miranda; Víctor A Francis; Joan Vendrell; Antonio Zorzano; Aurelio A Teleman
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

Review 4.  Adaptive mechanisms to compensate for overnutrition-induced cardiovascular abnormalities.

Authors:  Lakshmi Pulakat; Vincent G DeMarco; Sivakumar Ardhanari; Anand Chockalingam; Rukhsana Gul; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-03       Impact factor: 3.619

Review 5.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

Authors:  Philippe Gual; Yannick Le Marchand-Brustel; Jean-François Tanti
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

6.  Indices of obesity and cardiometabolic risk.

Authors:  Adam Whaley-Connell; James R Sowers
Journal:  Hypertension       Date:  2011-10-24       Impact factor: 10.190

7.  PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.

Authors:  G Wolf; T Trüb; E Ottinger; L Groninga; A Lynch; M F White; M Miyazaki; J Lee; S E Shoelson
Journal:  J Biol Chem       Date:  1995-11-17       Impact factor: 5.157

Review 8.  Cardiac insulin resistance and microRNA modulators.

Authors:  Lakshmi Pulakat; Annayya R Aroor; Rukhsana Gul; James R Sowers
Journal:  Exp Diabetes Res       Date:  2011-07-31

9.  Skeletal muscle protein tyrosine phosphatase 1B regulates insulin sensitivity in African Americans.

Authors:  April J Stull; Zhong Q Wang; Xian H Zhang; Yongmei Yu; William D Johnson; William T Cefalu
Journal:  Diabetes       Date:  2012-04-03       Impact factor: 9.461

10.  UCF-101 mitigates streptozotocin-induced cardiomyocyte dysfunction: role of AMPK.

Authors:  Qun Li; Ji Li; Jun Ren
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 5.900

View more
  10 in total

1.  Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic β-cells.

Authors:  Xiangmin Zhang; Divyasri Damacharla; Danjun Ma; Yue Qi; Rebecca Tagett; Sorin Draghici; Anjaneyulu Kowluru; Zhengping Yi
Journal:  Mol Cell Endocrinol       Date:  2016-01-09       Impact factor: 4.102

2.  Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.

Authors:  Nancy J Hançer; Wei Qiu; Christine Cherella; Yedan Li; Kyle D Copps; Morris F White
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

3.  Adiponectin inhibits insulin function in primary trophoblasts by PPARα-mediated ceramide synthesis.

Authors:  Irving L M H Aye; Xiaoli Gao; Susan T Weintraub; Thomas Jansson; Theresa L Powell
Journal:  Mol Endocrinol       Date:  2014-02-25

Review 4.  Current perspectives of oleic acid: Regulation of molecular pathways in mitochondrial and endothelial functioning against insulin resistance and diabetes.

Authors:  Kanwal Rehman; Kamran Haider; Komal Jabeen; Muhammad Sajid Hamid Akash
Journal:  Rev Endocr Metab Disord       Date:  2020-12       Impact factor: 6.514

5.  Branched-chain ketoacid overload inhibits insulin action in the muscle.

Authors:  Dipsikha Biswas; Khoi T Dao; Angella Mercer; Andrew M Cowie; Luke Duffley; Yassine El Hiani; Petra C Kienesberger; Thomas Pulinilkunnil
Journal:  J Biol Chem       Date:  2020-09-02       Impact factor: 5.157

6.  Family with sequence similarity 13, member A modulates adipocyte insulin signaling and preserves systemic metabolic homeostasis.

Authors:  Donytra Arby Wardhana; Koji Ikeda; Agian Jeffilano Barinda; Dhite Bayu Nugroho; Kikid Rucira Qurania; Keiko Yagi; Keishi Miyata; Yuichi Oike; Ken-Ichi Hirata; Noriaki Emoto
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-31       Impact factor: 11.205

7.  Melatonin and Nitrones As Potential Therapeutic Agents for Stroke.

Authors:  Alejandro Romero; Eva Ramos; Paloma Patiño; Maria J Oset-Gasque; Francisco López-Muñoz; José Marco-Contelles; María I Ayuso; Alberto Alcázar
Journal:  Front Aging Neurosci       Date:  2016-11-23       Impact factor: 5.750

8.  FAM122A, a new endogenous inhibitor of protein phosphatase 2A.

Authors:  Li Fan; Man-Hua Liu; Meng Guo; Chuan-Xi Hu; Zhao-Wen Yan; Jing Chen; Guo-Qiang Chen; Ying Huang
Journal:  Oncotarget       Date:  2016-09-27

9.  DCAF7 regulates cell proliferation through IRS1-FOXO1 signaling.

Authors:  Scott Frendo-Cumbo; Taoyingnan Li; Dustin A Ammendolia; Etienne Coyaud; Estelle M N Laurent; Yuan Liu; Philip J Bilan; Gordon Polevoy; Brian Raught; Julie A Brill; Amira Klip; John H Brumell
Journal:  iScience       Date:  2022-09-24

10.  Increased interaction with insulin receptor substrate 1, a novel abnormality in insulin resistance and type 2 diabetes.

Authors:  Michael Caruso; Danjun Ma; Zaher Msallaty; Monique Lewis; Berhane Seyoum; Wissam Al-janabi; Michael Diamond; Abdul B Abou-Samra; Kurt Højlund; Rebecca Tagett; Sorin Draghici; Xiangmin Zhang; Jeffrey F Horowitz; Zhengping Yi
Journal:  Diabetes       Date:  2014-02-28       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.